C Oberhoff

Summary

Affiliation: University of Essen
Country: Germany

Publications

  1. ncbi request reprint Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil
    R A Hilger
    Department of Internal Medicine Cancer Research, University of Essen Medical School, West German Cancer Center, Essen, Germany
    Int J Clin Pharmacol Ther 43:588-9. 2005
  2. ncbi request reprint Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study
    C Oberhoff
    Center for Gynecology and Obstetrics, University Hospital, Essen, Germany
    Ann Oncol 9:255-60. 1998
  3. ncbi request reprint Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis
    C Oberhoff
    Center of Gynecology and Obstetrics, University Hospital Essen, Germany
    Breast Cancer Res Treat 50:73-81. 1998
  4. ncbi request reprint Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study
    C Oberhoff
    Abteilung für Gynäkologie, Zentrum fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Onkologie 24:256-60. 2001
  5. ncbi request reprint Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer
    C Oberhoff
    University Hospital Essen, Center of Gynecology and Obstetrics, Department of Gynecological Oncology, Hufelandstr. 55, D-45122 Essen, Germany
    Gynecol Endocrinol 15:341-8. 2001
  6. ncbi request reprint Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
    R A Hilger
    Innere Klinik und Poliklinik Tumorforschung, Universitatsklinikum Essen, Westdeutsches Tumorzentrum, Germany
    Cancer Chemother Pharmacol 45:483-8. 2000
  7. ncbi request reprint High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer
    P Bojko
    University of Essen, Department of Internal Medicine, West German Cancer Center, Hufelandstrasse 55, 45122 Essen, Germany
    J Cancer Res Clin Oncol 127:243-50. 2001
  8. ncbi request reprint Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    A Welt
    Department of Internal Medicine Cancer Research, West German Cancer Center, University of Duisburg Essen Medical School, Essen, Germany
    Ann Oncol 16:64-9. 2005
  9. ncbi request reprint [Pros and cons of early cancer detection in breast carcinoma]
    R Callies
    Klinik fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen
    MMW Fortschr Med 147:30-2. 2005
  10. ncbi request reprint A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)
    S Kasimir-Bauer
    Department of Internal Medicine Cancer Research, West German Cancer Center, Essen
    Int J Oncol 20:1027-34. 2002

Collaborators

Detail Information

Publications12

  1. ncbi request reprint Pharmacokinetics (PK) of a liposomal encapsulated fraction containing doxorubicin and of doxorubicin released from the liposomal capsule after intravenous infusion of Caelyx/Doxil
    R A Hilger
    Department of Internal Medicine Cancer Research, University of Essen Medical School, West German Cancer Center, Essen, Germany
    Int J Clin Pharmacol Ther 43:588-9. 2005
  2. ncbi request reprint Recombinant human erythropoietin in the treatment of chemotherapy-induced anemia and prevention of transfusion requirement associated with solid tumors: a randomized, controlled study
    C Oberhoff
    Center for Gynecology and Obstetrics, University Hospital, Essen, Germany
    Ann Oncol 9:255-60. 1998
    ..Recombinant human erythropoietin (rhEPO) provides a new treatment modality for chemotherapy-induced anemia...
  3. ncbi request reprint Adjuvant antiestrogen treatment with tamoxifen in postmenopausal women with breast cancer: a longitudinal study of blood coagulation and fibrinolysis
    C Oberhoff
    Center of Gynecology and Obstetrics, University Hospital Essen, Germany
    Breast Cancer Res Treat 50:73-81. 1998
    ..Therefore our results are likely to reflect only the resolution of postoperative activation and do not translate into a drug related thrombogenic effect...
  4. ncbi request reprint Topotecan chemotherapy in patients with breast cancer and brain metastases: results of a pilot study
    C Oberhoff
    Abteilung für Gynäkologie, Zentrum fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen, Hufelandstrasse 55, D 45122 Essen, Germany
    Onkologie 24:256-60. 2001
    ..To evaluate the role of topotecan as a primary chemotherapy for brain metastases, we performed a pilot study in patients with metastatic breast cancer...
  5. ncbi request reprint Hemostatic effects of high-dose megestrol acetate therapy in patients with advanced gynecological cancer
    C Oberhoff
    University Hospital Essen, Center of Gynecology and Obstetrics, Department of Gynecological Oncology, Hufelandstr. 55, D-45122 Essen, Germany
    Gynecol Endocrinol 15:341-8. 2001
    ..The observed incidence of thrombosis might be the consequence of other risk factors such as tumor-induced hypercoagulability, simultaneous chemotherapy or other individual thrombosis risk factors...
  6. ncbi request reprint Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancer
    R A Hilger
    Innere Klinik und Poliklinik Tumorforschung, Universitatsklinikum Essen, Westdeutsches Tumorzentrum, Germany
    Cancer Chemother Pharmacol 45:483-8. 2000
    ..v.) treosulfan of 1.5 or 2.0 g daily for 5 to 8 days...
  7. ncbi request reprint High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancer
    P Bojko
    University of Essen, Department of Internal Medicine, West German Cancer Center, Hufelandstrasse 55, 45122 Essen, Germany
    J Cancer Res Clin Oncol 127:243-50. 2001
    ..We report the results of high-dose chemotherapy (HDC) with peripheral blood stem cell transplantation in twenty-one patients with primarily advanced or relapsed ovarian cancer...
  8. ncbi request reprint Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer
    A Welt
    Department of Internal Medicine Cancer Research, West German Cancer Center, University of Duisburg Essen Medical School, Essen, Germany
    Ann Oncol 16:64-9. 2005
    ..In addition, we aimed to obtain data on efficacy and safety at the recommended dose...
  9. ncbi request reprint [Pros and cons of early cancer detection in breast carcinoma]
    R Callies
    Klinik fur Frauenheilkunde und Geburtshilfe, Universitatsklinikum Essen
    MMW Fortschr Med 147:30-2. 2005
    ..Whether this actually succeeds depends upon the quality of the early detection strategies employed. Currently the data on reduction of mortality by mammographic screening remain ambivalent...
  10. ncbi request reprint A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review)
    S Kasimir-Bauer
    Department of Internal Medicine Cancer Research, West German Cancer Center, Essen
    Int J Oncol 20:1027-34. 2002
    ..Immunotherapeutic target antigens on the cell surface of these cells support the idea that a combined chemoimmunotherapy might be successful in eliminating minimal residual disease...
  11. ncbi request reprint Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial
    E Heidemann
    Department of Hematology and Medical Oncology, Deaconess Hospital, Oncological Center of Stuttgart, Germany
    Ann Oncol 13:1717-29. 2002
    ..To determine whether patients with high-risk metastatic breast cancer draw benefit from combination chemotherapy as first-line treatment...
  12. ncbi request reprint Epoetin beta (NeoRecormon) therapy in patients with solid tumours receiving platinum and non-platinum chemotherapy: a meta-analysis
    M Boogaerts
    University Hospital Gasthuisberg, Leuven, Belgium
    Anticancer Res 26:479-84. 2006
    ..Anaemia is a common complication of chemotherapy (CT), including both non-platinum (Pt)-based as well as Pt-based CT...